STERIS plc logo
STESTERIS plc

Revenue

Trailing-twelve-month (TTM) revenue is $5.94 Billion with a year-over-year growth of +8.73%. Revenue represents the total income generated from the company's primary business operations.

Revenue

STE Revenue

$1.59B

Reported quarterly revenue; no daily interpolation.

+64.02% 5Y

STE Quarterly Revenue Growth (YoY)

Revenue growth vs the same quarter one year earlier, last 20 quarters.

STE Revenue by Segment

How STE’s revenue breaks down across its reported segments in the latest reported fiscal year.

By product / business (FY 2026)

  • Product$3.06B51.6%
  • Services$2.88B48.4%

By geography (FY 2026)

  • United States$4.33B73.0%
  • Other foreign locations$1.49B25.2%
  • Ireland$108.50M1.8%

STE Revenue by Product / Business (history)

How the revenue mix has shifted across the last 6 reported fiscal years. Bar height tracks total revenue.

Product · FY2021: $1.4BServices · FY2021: $1.7BFY21Product · FY2022: $2.6BServices · FY2022: $2.0BFY22Product · FY2023: $2.8BServices · FY2023: $2.2BFY23Product · FY2024: $2.8BServices · FY2024: $2.4BFY24Product · FY2025: $2.9BServices · FY2025: $2.6BFY25Product · FY2026: $3.1BServices · FY2026: $2.9BFY26
  • Product
  • Services

Bars in years without a matched total revenue show the share of reported segments only.

STE Revenue by Geography (history)

How the revenue mix has shifted across the last 6 reported fiscal years. Bar height tracks total revenue.

United States · FY2021: $2.2BOther foreign locations · FY2021: $809MIreland · FY2021: $72MFY21United States · FY2022: $3.2BOther foreign locations · FY2022: $1.3BIreland · FY2022: $82MFY22United States · FY2023: $3.6BOther foreign locations · FY2023: $1.3BIreland · FY2023: $74MFY23United States · FY2024: $3.8BOther foreign locations · FY2024: $1.3BIreland · FY2024: $83MFY24United States · FY2025: $4.0BOther foreign locations · FY2025: $1.3BIreland · FY2025: $107MFY25United States · FY2026: $4.3BOther foreign locations · FY2026: $1.5BIreland · FY2026: $109MFY26
  • United States
  • Other foreign locations
  • Ireland

Bars in years without a matched total revenue show the share of reported segments only.

Revenue (TTM)

$5.94B

$5.94 Billion

Year-over-Year Growth

+8.73%

vs. $5.46B a year ago (TTM)

Revenue CAGR

+13.82%

5 Year compound annual growth rate

Revenue CAGR (Compound Annual Growth Rate)

1 Year

+8.73%

3 Year

+6.18%

5 Year

+13.82%

10 Year

+10.24%

15 Year

+11.20%

20 Year

+8.50%

CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.

Annual Revenue History

YearRevenueYoY Change% Change
2026$5.94B+$476.38M+8.73%
2025$5.46B+$320.81M+6.24%
2024$5.14B+$602.43M+13.28%
2023$4.54B+$312.86M+7.41%
2022$4.22B+$1.12B+35.91%
2021$3.11B+$76.62M+2.53%
2020$3.03B+$248.72M+8.94%
2019$2.78B+$162.17M+6.19%
2018$2.62B+$7.24M+0.28%
2017$2.61B+$373.99M+16.71%

Revenue Growth Summary

TTM Growth

+8.73%

3-Year Avg Growth

+6.18%

5-Year Avg Growth

+13.82%

Data as of Friday, June 26, 2026

About STERIS plc

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Mentor, OH
17,840 employees
Healthcare / Medical - Equipment & Services
Sector
Healthcare
Industry
Medical - Equipment & Services
CEO
Daniel A. Carestio